An antiplatelet drug used to reduce the risk of a heart attack during coronary surgery.
Abciximab, a glycoprotein IIb/IIIa receptor antagonist manufactured by Janssen Biologics BV and distributed by Eli Lilly under the trade name ReoPro, is a platelet aggregation inhibitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus formation within the coronary artery. It is a glycoprotein IIb/IIIa inhibitor. While Abciximab has a short plasma half-life, due to its strong affinity for its receptor on the platelets, it may occupy some receptors for weeks. In practice, platelet aggregation gradually returns to normal about 96 to 120 hours after discontinuation of the drug.
The numerical value of abciximab in Chaldean Numerology is: 2
The numerical value of abciximab in Pythagorean Numerology is: 1
Images & Illustrations of abciximab
Find a translation for the abciximab definition in other languages:
Select another language: